Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP194643.RAZ8Igsl194c4SElUyDb31NvnltTpjEatk4e1OGc9D-VQ130_assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP194643.RAZ8Igsl194c4SElUyDb31NvnltTpjEatk4e1OGc9D-VQ130_provenance.
• assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP373261.RASyyC5HWnoGA3lK7xuC_o_7e7lPA63aRnkvZZcK759ZY130_assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP373261.RASyyC5HWnoGA3lK7xuC_o_7e7lPA63aRnkvZZcK759ZY130_provenance.
• NP374564.RAffzoFE1dWFb1huVtOiAukkMokM2QEYvQ6-BTbDpHfPo130_assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP374564.RAffzoFE1dWFb1huVtOiAukkMokM2QEYvQ6-BTbDpHfPo130_provenance.
• NP191385.RAhNikuMBnO84Xig6MZVW8QyBC34SgDS9n0Jep8xk97Ms130_assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP191385.RAhNikuMBnO84Xig6MZVW8QyBC34SgDS9n0Jep8xk97Ms130_provenance.
• assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP433578.RAbrnBbSxY2pxr4SHQ2LsSLE6vZtSvAb6x22c1E8Nycr0130_assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433578.RAbrnBbSxY2pxr4SHQ2LsSLE6vZtSvAb6x22c1E8Nycr0130_provenance.
• assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP402178.RADYS4G8Uajq2WqYoamymUYFWBzCiMGLmwL-XzyNSBcR8130_assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402178.RADYS4G8Uajq2WqYoamymUYFWBzCiMGLmwL-XzyNSBcR8130_provenance.
• NP402175.RAWbXk4NJugTQIVTaHKn-yKad6lgLGZvaRKY7WjwRUab4130_assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402175.RAWbXk4NJugTQIVTaHKn-yKad6lgLGZvaRKY7WjwRUab4130_provenance.
• NP402176.RAcIdE9gpn6izXzt7nLNXdJCU0vecqThjcJt_SRSscRig130_assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402176.RAcIdE9gpn6izXzt7nLNXdJCU0vecqThjcJt_SRSscRig130_provenance.
• NP402182.RAfYOxToXrXLJGygiCR99VSzvL4T7kLnpqo-SyP_2hsw4130_assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402182.RAfYOxToXrXLJGygiCR99VSzvL4T7kLnpqo-SyP_2hsw4130_provenance.
• NP402185.RAWMxkHf6fM2JD9N7hlOSyzGlI1B9AdxjzvG6ekROA8tk130_assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402185.RAWMxkHf6fM2JD9N7hlOSyzGlI1B9AdxjzvG6ekROA8tk130_provenance.
• NP402187.RAc1SxCvLL2MfBPsu-Z2dPQMy3B2PcEU6SYIzLLOEuEWs130_assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402187.RAc1SxCvLL2MfBPsu-Z2dPQMy3B2PcEU6SYIzLLOEuEWs130_provenance.
• NP402190.RAT2fNAee47YSEAeFH_Vn-6AthVPKN88vMUmZfMg7wwv0130_assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402190.RAT2fNAee47YSEAeFH_Vn-6AthVPKN88vMUmZfMg7wwv0130_provenance.
• NP433629.RADM2ch1Nkc6UpAOcoG_rg7THaKpgviwo92Xw74HUnZJw130_assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433629.RADM2ch1Nkc6UpAOcoG_rg7THaKpgviwo92Xw74HUnZJw130_provenance.
• NP402177.RAt5c4pXvJxNfaRzqONbA-UqDxKnjpVKi6koH1NX55FXI130_assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402177.RAt5c4pXvJxNfaRzqONbA-UqDxKnjpVKi6koH1NX55FXI130_provenance.
• NP402184.RApzkBElWCg7ChR1XqC7ZVnSyCu14dy2Tgh9TCmLaI2ZU130_assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402184.RApzkBElWCg7ChR1XqC7ZVnSyCu14dy2Tgh9TCmLaI2ZU130_provenance.
• NP402188.RAt7JLloBMsPzqiXy_WSmeIMJzEeU5ZZxAOZ_UhjF6kZo130_assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402188.RAt7JLloBMsPzqiXy_WSmeIMJzEeU5ZZxAOZ_UhjF6kZo130_provenance.
• NP402183.RAPiLxuHK7uYtROAku5DYXa1p-6QAAn8oYSFSk0A9Xg0o130_assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402183.RAPiLxuHK7uYtROAku5DYXa1p-6QAAn8oYSFSk0A9Xg0o130_provenance.
• NP402179.RA1jPIsqERyl-dTSQjsHaWCm5VukwQ4IVG-shwEr8Z_uo130_assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402179.RA1jPIsqERyl-dTSQjsHaWCm5VukwQ4IVG-shwEr8Z_uo130_provenance.
• NP402181.RAxGNnch_ZyrbrIRDsQZWmkelWd8-oQhSyhMNucWrynok130_assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402181.RAxGNnch_ZyrbrIRDsQZWmkelWd8-oQhSyhMNucWrynok130_provenance.
• NP402186.RA6ufMdztOZfoJ5GWtfs7WWDbt95gfdhfVAyXLj-f28go130_assertion description "[Our results point to the involvement of several ErbB-specific ligands (amphiregulin and neuregulin 1) and enzymes or adaptor molecules (PI3K, Src, Shc and Grb7) in the ErbB pathway dysregulation associated with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402186.RA6ufMdztOZfoJ5GWtfs7WWDbt95gfdhfVAyXLj-f28go130_provenance.